Newswise — Falls Church, Virginia. Sep. 20, 2012—An international community of researchers, clinicians and health care professionals will convene at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada, held Sept. 19 – Sept. 23, to present and discuss today’s most promising clinical, translational, and basic science research focused on thyroid diseases and disorders.
This four-day scientific summit will feature best-in-class sessions on the latest advances in thyroidology. The ATA Program Committee, chaired by Elizabeth Pearce, MD, Boston Medical Center, and Douglas Forrest, PhD, National Institute of Diabetes and Digestive and Kidney Diseases, have crafted an array of symposia, “meet-the-professor” workshops, interactive sessions, poster review opportunities, and oral abstract presentations that capture the latest information from leaders in basic science and clinical research and its relevance for disease management and patient care.
The Meeting will include two plenary lectures delivered by world-renowned researchers, Nancy Carrasco, MD, of the Yale School of Medicine, and Krishna Chatterjee, MD, of the Institute of Metabolic Science at University of Cambridge (UK). Dr. Carrasco will discuss her research on the Na+/I- symporter (NIS), the key plasma membrane protein that mediates active iodide transport in the thyroid and other tissues, and Dr. Chatterjee, MD, discuss the role of selenoprotein signaling in the development of thyroid hormone disorders.
Among the Meeting’s most anticipated events is the bestowal of the Association’s distinguished awards. This year's honorees include Fredric Wondisford, MD, of Johns Hopkins University, who will receive the Sidney Ingbar Distinguished Lectureship Award; Paul W. Ladenson, MD, of Johns Hopkins University, who will receive the Lewis E. Braverman Award; Sandra McLachlan, PhD, of Cedars-Sinai Medical Center, who will receive the John B. Stanbury Pathophysiology Medal; Bryan R. Haugen, MD, of the University of Colorado, who will receive the Paul Starr Award; and, Richard T. Kloos, MD, of Veracyte, Inc., who will receive the Distinguished Service Award. The recipient of the prestigious Van Meter Lectureship will be announced onsite.
Attendees can start their days with the Early Riser Symposia, participate in lectures and interactive discussions, network with colleagues and learn about professional development opportunities, review cutting-edge research presented during the poster sessions, and visit the Exhibit Hall where industry representatives look forward to sharing information about their new services, products, and state-of-the-art technologies. As in years past, the ATA Meeting offers customized educational tracks for ATA Fellows in clinical and basic science, as well as a newly developed surgical track, to enhance their meeting experience.
In addition to the general meeting program, the ATA Alliance for Patient Education will offer a free Public Health Forum, "Thyroid Disease and You," on Saturday, Sept. 22, from 1:00-3:00 p.m. at the Hilton Quebec. Physician experts will discuss thyroid cancer and other thyroid disorders. Reservations are encouraged. For more information and to register, e-mail [email protected]
About the ATA Annual Meeting The 82nd Annual Meeting of the American Thyroid Association is held Sept.19-23, in Québec City, Québec, Canada. This four-day creative and innovative scientific program, chaired by Elizabeth Pearce, MD, Boston Medical Center, and Douglas Forrest, PhD, National Institute of Diabetes and Digestive and Kidney Diseases, carefully balances clinical and basic science sessions on the latest advances in thyroidology. The ATA meeting is designed to offer continuing education for endocrinologists, internists, surgeons, basic scientists, nuclear medicine scientists, pathologists, endocrine fellows and nurses, physician assistants and other health care professionals. Visit www.thyroid.org for more information.
About the ATA The American Thyroid Association (ATA) is the leading worldwide organization dedicated to the advancement, understanding, prevention, diagnosis and treatment of thyroid disorders and thyroid cancer. ATA is an international individual membership organization with over 1,600 members from 43 countries around the world. Celebrating its 89th anniversary, ATA delivers its mission through several key endeavors: the publication of highly regarded monthly journals, THYROID, Clinical Thyroidology and Clinical Thyroidology for Patients; annual scientific meetings; biennial clinical and research symposia; research grant programs for young investigators, support of online professional, public and patient educational programs through www.thyroid.org; and the development of guidelines for clinical management of thyroid disease. Visit www.thyroid.org for more information.
# # #